GSK Pharma posts Q4 net profit of Rs 1219 crore

GSK Pharma posts Q4 net profit of Rs 1219 crore

GSK Pharma, also known as GlaxoSmithKline Pharmaceuticals Limited, reported a consolidated net profit of Rs 1219.05 crore for the fourth quarter ended March 2022.

The company had a net profit of 14.33 crore for the period previous fiscal, as per the BSE filing of GlaxoSmithKline Pharmaceuticals.

Its consolidated revenues from operations stood at Rs 809.63 crore for the quarter under consideration. It was a year ago, when it was Rs 744.43 crore.

The company posted a net profit of Rs 1694.72 crore for the entire 2021 -- 22 period, against Rs 358.15 crore in the previous fiscal, according to the filing.

Its board has recommended a dividend of Rs. For the year ended March 31, 2022, there are 90 per equity shares on the face value of 10 per share. This includes a special dividend of 60.

The recommendation of the Board is subject to the approval of members at the 97th Annual General Meeting on Tuesday, July 26. The dividend if approved by the members will be paid on or after July 27th, 2022.

The shares of GlaxoSmithKline Pharmaceuticals closed at Rs 1,514. The price of the BSE went up by 1.42 per cent from its previous close.